Marshall Wace North America’s GoodRx Holdings GDRX Stock Holding History

Marshall Wace North America’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$14.1M	Buy	+342,646	New	+$12.4M	0.06%	296
2021 Q2	–	Sell	-685,163	Closed	-$26.7M	–	1566
2021 Q1	$26.7M	Buy	685,163 +227,280	+50%	+$10.2M	0.11%	210
2020 Q4	$18.5M	Sell	457,883 -95,090	-17%	-$4.37M	0.08%	271
2020 Q3	$30.7M	Buy	+552,973	New	+$29.3M	0.2%	133

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

Marshall Wace North America's GDRX Position: Q3 2021 in Review

Marshall Wace North America opened a new position in GoodRx Holdings (GDRX) in Q3 2021: 342,646 shares worth $14.1M. The stake represents 0.06% of the portfolio and ranks #296 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in GDRX as recently as Q1 2021.

Marshall Wace North America first reported a position in GDRX in Q3 2020 and has held it in 4 quarters since. The position peaked at $30.7M in Q3 2020. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

Marshall Wace North America held 342,646 shares of GoodRx Holdings worth $14.1M as of Q3 2021.
GoodRx Holdings was a new Marshall Wace North America position in Q3 2021.
GoodRx Holdings made up 0.06% of Marshall Wace North America's portfolio in Q3 2021, its #296 holding.
Marshall Wace North America first reported a position in GoodRx Holdings in Q3 2020 and has held it in 4 quarters since.
Marshall Wace North America's GoodRx Holdings position peaked at $30.7M in Q3 2020.
218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.